Article · 2025
OtherPublished 28 Jan 2022
BCG vaccine and Immunodeficiency
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis (TB) is considered by WHO as global health emergency in 1993. In 2011 one third of the world’s population was thought to be infected with TB and 8.7 million cases of active TB annually. BCG vaccine is one of the effective control measures to prevent TB. It is in practice since 1960s where TB is highly prevalent and 120 million BCG vaccines are given annually, that is effective in preventing severe disease of extrapulmonary TB. BCG vaccine is alive attenuated vaccine that potentially could prevent TB meningitis and disseminated diseases. However, it could cause local infection, in about 1:10,000 to 1:1,000,000 in immune competent individuals and significantly higher when given to immunodeficient subjects. Immunodeficient infants who receive BCG vaccine at birth could develop disseminated BCGitis, which is associated with high morbidity and mortality. However, those who develop disseminated BCGitis usually require hospital admissions and multiple medications with high cost and low survival rate ranging between 0% to 65% worldwide. Our center; KAMC WR, Jeddah Saudi Arabia, has 83% survival rate of treating patients with disseminated BCGitis, but with using cytokine therapy and aminoglycoside drug in addition to common anti TB drugs.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Health and Medical Research.
Article · 10 Jan 2024
The Implementation and Success of Community Based Education and Research Services and Inter-Profession Education Programme at a Rural Health Sciences Faculty in Uganda: Case of Busitema University
Perspective · 26 Apr 2023
Biochemical Prospects and Major Obstacles in Nano-Vaccinology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Health and Medical Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Daifulah Alzahrani”

